These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 34010151)
1. SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer. Jin M; Lee WK; You MH; Jang A; Cheng SY; Kim WG; Jeon MJ; Lee YM Endocr Connect; 2021 Jun; 10(6):630-636. PubMed ID: 34010151 [TBL] [Abstract][Full Text] [Related]
2. SHMT2 Induces Stemness and Progression of Head and Neck Cancer. Jin Y; Jung SN; Lim MA; Oh C; Piao Y; Kim HJ; Nguyena Q; Kang YE; Chang JW; Won HR; Koo BS Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077112 [TBL] [Abstract][Full Text] [Related]
3. The expression and clinical significance of serine hydroxymethyltransferase2 in gastric cancer. Shan Y; Liu D; Li Y; Wu C; Ye Y PeerJ; 2024; 12():e16594. PubMed ID: 38188143 [TBL] [Abstract][Full Text] [Related]
6. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients. Shi H; Fang X; Li Y; Zhang Y Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160 [TBL] [Abstract][Full Text] [Related]
7. Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer. Wang H; Chong T; Li BY; Chen XS; Zhen WB Biol Res; 2020 Oct; 53(1):46. PubMed ID: 33066813 [TBL] [Abstract][Full Text] [Related]
8. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker. Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119 [TBL] [Abstract][Full Text] [Related]
9. Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma. Wu ZZ; Wang S; Yang QC; Wang XL; Yang LL; Liu B; Sun ZJ Front Oncol; 2020; 10():588530. PubMed ID: 33163414 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer. Zhang P; Yang Q Front Genet; 2021; 12():682856. PubMed ID: 34149818 [TBL] [Abstract][Full Text] [Related]
11. High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors. Liu Y; Yin C; Deng MM; Wang Q; He XQ; Li MT; Li CP; Wu H Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9379-9392. PubMed ID: 31773687 [TBL] [Abstract][Full Text] [Related]
12. Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype. Sun WY; Kim HM; Jung WH; Koo JS J Transl Med; 2016 Jun; 14(1):168. PubMed ID: 27277113 [TBL] [Abstract][Full Text] [Related]
13. Biotinidase is a novel marker for papillary thyroid cancer aggressiveness. So AK; Kaur J; Kak I; Assi J; MacMillan C; Ralhan R; Walfish PG PLoS One; 2012; 7(7):e40956. PubMed ID: 22911723 [TBL] [Abstract][Full Text] [Related]
14. Noncoding RNAs in Papillary Thyroid Cancer: Interaction with Cancer-Associated Fibroblasts (CAFs) in the Tumor Microenvironment (TME) and Regulators of Differentiation and Lymph Node Metastasis. Dadafarin S; Carnazza M; Islam HK; Moscatello A; Tiwari RK; Geliebter J Adv Exp Med Biol; 2021; 1350():145-155. PubMed ID: 34888848 [TBL] [Abstract][Full Text] [Related]
15. Identification of an immune-related signature indicating the dedifferentiation of thyroid cells. Wang X; Peng W; Li C; Qin R; Zhong Z; Sun C Cancer Cell Int; 2021 Apr; 21(1):231. PubMed ID: 33892730 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas. Wu M; Wanggou S; Li X; Liu Q; Xie Y Onco Targets Ther; 2017; 10():3781-3788. PubMed ID: 28794642 [TBL] [Abstract][Full Text] [Related]
17. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma. Luo L; Zheng Y; Lin Z; Li X; Li X; Li M; Cui L; Luo H J Immunol Res; 2021; 2021():6647122. PubMed ID: 33928169 [TBL] [Abstract][Full Text] [Related]
18. Not the same thing: metastatic PTCs have a different background than ATCs. de Biase D; Torricelli F; Ragazzi M; Donati B; Kuhn E; Visani M; Acquaviva G; Pession A; Tallini G; Piana S; Ciarrocchi A Endocr Connect; 2018 Dec; 7(12):1370-1379. PubMed ID: 30400028 [TBL] [Abstract][Full Text] [Related]
19. PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma. Xing X; Mu N; Yuan X; Wang N; Juhlin CC; Strååt K; Larsson C; Xu D Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32752127 [TBL] [Abstract][Full Text] [Related]
20. Positive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade. Yin K Onco Targets Ther; 2015; 8():1069-74. PubMed ID: 25999742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]